Wall Street brokerages expect that Nu Skin Enterprises (NYSE:NUS) will report $0.67 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings, with the lowest EPS estimate coming in at $0.65 and the highest estimate coming in at $0.69. Nu Skin Enterprises reported earnings per share of $0.51 in the same quarter last year, which would indicate a positive year-over-year growth rate of 31.4%. The business is scheduled to announce its next earnings results after the market closes on Thursday, April 26th.
On average, analysts expect that Nu Skin Enterprises will report full-year earnings of $3.56 per share for the current financial year, with EPS estimates ranging from $3.53 to $3.58. For the next financial year, analysts anticipate that the business will post earnings of $3.72 per share. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, February 15th. The company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.19 by $0.01. The firm had revenue of $666.20 million for the quarter, compared to analyst estimates of $667.39 million. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The business’s revenue for the quarter was up 25.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.79 EPS.
Nu Skin Enterprises stock traded up $0.66 during mid-day trading on Friday, reaching $73.71. 432,510 shares of the company’s stock were exchanged, compared to its average volume of 670,861. The firm has a market cap of $3,888.20, a PE ratio of 22.82, a price-to-earnings-growth ratio of 2.05 and a beta of 1.43. Nu Skin Enterprises has a twelve month low of $52.88 and a twelve month high of $75.00. The company has a quick ratio of 1.17, a current ratio of 1.74 and a debt-to-equity ratio of 0.44.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 14th. Shareholders of record on Monday, February 26th were given a $0.365 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.36. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.98%. Nu Skin Enterprises’s dividend payout ratio is currently 45.20%.
In other Nu Skin Enterprises news, Director Pisano R. Thomas sold 15,000 shares of the stock in a transaction that occurred on Wednesday, March 7th. The shares were sold at an average price of $72.00, for a total value of $1,080,000.00. Following the sale, the director now directly owns 47,437 shares of the company’s stock, valued at approximately $3,415,464. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Mark H. Lawrence sold 724 shares of the stock in a transaction that occurred on Friday, March 9th. The shares were sold at an average price of $72.86, for a total transaction of $52,750.64. Following the completion of the sale, the chief financial officer now directly owns 11,473 shares in the company, valued at $835,922.78. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,593 shares of company stock worth $3,933,622. Insiders own 5.20% of the company’s stock.
Several large investors have recently made changes to their positions in the business. Old Mutual Global Investors UK Ltd. grew its position in shares of Nu Skin Enterprises by 63.1% in the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 821,316 shares of the company’s stock valued at $56,038,000 after buying an additional 317,869 shares during the last quarter. APG Asset Management N.V. grew its position in shares of Nu Skin Enterprises by 159.2% in the 4th quarter. APG Asset Management N.V. now owns 402,500 shares of the company’s stock valued at $22,870,000 after buying an additional 247,200 shares during the last quarter. Renaissance Technologies LLC purchased a new position in shares of Nu Skin Enterprises in the 4th quarter valued at $13,373,000. UBS Asset Management Americas Inc. grew its position in shares of Nu Skin Enterprises by 381.4% in the 4th quarter. UBS Asset Management Americas Inc. now owns 224,985 shares of the company’s stock valued at $15,351,000 after buying an additional 178,250 shares during the last quarter. Finally, Capital Fund Management S.A. grew its position in shares of Nu Skin Enterprises by 134.6% in the 4th quarter. Capital Fund Management S.A. now owns 182,305 shares of the company’s stock valued at $12,439,000 after buying an additional 104,600 shares during the last quarter. 76.48% of the stock is currently owned by institutional investors.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.